This year’s American Association of Pharmaceutical Scientists National Biotechnology Conference will feature two speakers from the RNAi field.
John Rossi, from the City of Hope’s Beckman Research Institute, is scheduled to present his preclinical work on treating HIV using RNAi.
Sirna Therapeutics’ COO Nassim Usman is also slated to discuss his company’s work using RNAi to treat age-related macular degeneration.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
